Evidence map›Paper›PMID 39451763›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their Caregivers.

Anna Fischl, Michael Gerken, Patricia Lindberg-Scharf, Tareq M Haedenkamp, Katharina Rosengarth, Andrea Hillberg, Martin Vogelhuber, Ingrid Schön, Martin Proescholdt, Tommaso Araceli and 10 more

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Impact of patient education and care on quality of life and mental well-being in cancer patients undergoing radiotherapy: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Anna FischlDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.
Michael GerkenCenter for Quality Assurance and Health Services Research, University of Regensburg, 93053 Regensburg, Germany.
Patricia Lindberg-ScharfCenter for Quality Assurance and Health Services Research, University of Regensburg, 93053 Regensburg, Germany.
Tareq M HaedenkampDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.
Katharina RosengarthDepartment of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, Germany.
Andrea HillbergDepartment of Internal Medicine III, Regensburg University Hospital, 93053 Regensburg, Germany.
Martin VogelhuberDepartment of Internal Medicine III, Regensburg University Hospital, 93053 Regensburg, Germany.
Ingrid SchönDepartment of Internal Medicine III, Regensburg University Hospital, 93053 Regensburg, Germany.
Martin ProescholdtDepartment of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, Germany.
Tommaso AraceliDepartment of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, Germany.
Michael KollerCenter for Clinical Trials, Regensburg University Hospital, 93053 Regensburg, Germany.
Anne HerrmannDepartment of Epidemiology and Preventive Medicine/Medical Sociology, University of Regensburg, 93053 Regensburg, Germany.
Oliver KölblDepartment of Radiotherapy, Regensburg University Hospital, 93053 Regensburg, Germany.
Tobias PukropDepartment of Internal Medicine III, Regensburg University Hospital, 93053 Regensburg, Germany.ORCID 0000-0001-8781-8187
Markus J RiemenschneiderDepartment of Neuropathology, Regensburg University Hospital, 93053 Regensburg, Germany.
Nils Ole SchmidtDepartment of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, Germany.ORCID 0000-0001-6910-8843
Monika Klinkhammer-SchalkeCenter for Quality Assurance and Health Services Research, University of Regensburg, 93053 Regensburg, Germany.
Ralf LinkerDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.
Peter HauDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.ORCID 0000-0003-3894-5053
Elisabeth BumesDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.ORCID 0000-0001-6915-3206

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Clinical aspects like sex, age, Karnofsky Performance Scale (KPS) and psychosocial distress can affect the health-related quality of life (HR-QoL) and treatment satisfaction of patients with malignant isocitrate dehydrogenase wild-type (IDHwt) gliomas and caregivers. (2) Methods: We prospectively investigated the HR-QoL and patient/caregiver treatment satisfaction in a cross-sectional study with univariable and multiple regression analyses. Questionnaires were applied to investigate the HR-QoL (EORTC QLQ-C30, QLQ-BN20) and treatment satisfaction (EORTC PATSAT-C33). (3) Results: A cohort of 61 patients was investigated. A higher KPS was significantly associated with a better HR-QoL regarding the functional scales of the EORTC QLQ-C30 (

Indexed as

Brain NeoplasmsCaregiversGliomaIsocitrate DehydrogenasePatient SatisfactionQuality of LifeAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedProspective StudiesSurveys and QuestionnairesIsocitrate Dehydrogenasegliomahealth-related quality of lifeHR-QoLIDH wild-typepsycho-oncologysatisfaction

Identifiers

PMID39451763
PMCPMC11506037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.